Leu-Pro-Phe-Phe-Asp

Leu-Pro-Phe-Phe-Asp is a synthetic pentapeptide composed of the amino acids leucine, proline, phenylalanine, phenylalanine, and aspartic acid, arranged in a specific sequence. As a peptide compound, it serves as a valuable molecular tool in peptide-based research, offering unique physicochemical properties and sequence-specific biological relevance. Its defined structure enables researchers to investigate sequence-dependent functions, protein-peptide interactions, and the role of short peptides in cellular signaling or regulatory processes. The pentapeptide's combination of hydrophobic and acidic residues provides a versatile scaffold for exploring both structural and functional aspects of peptide chemistry, making it a noteworthy reagent for diverse experimental applications in the life sciences.

Peptide structure-activity relationship studies: In the field of peptide research, Leu-Pro-Phe-Phe-Asp is frequently utilized to dissect the relationship between primary sequence and biological activity. Its defined arrangement of amino acids allows researchers to systematically evaluate how subtle changes in sequence or residue composition influence receptor binding, enzymatic recognition, or bioactive conformations. By employing this pentapeptide as a reference or template, scientists can elucidate critical motifs responsible for activity, thereby informing the design of more potent or selective analogs in fundamental peptide science.

Protein-peptide interaction assays: The pentapeptide serves as an informative probe in studies aimed at characterizing protein-peptide interactions, particularly those involving recognition motifs or binding domains. Its sequence, featuring both hydrophobic and charged residues, makes it suitable for mapping interaction surfaces on proteins such as receptors, enzymes, or transporters. By incorporating it into binding assays or affinity studies, researchers can identify key determinants of specificity and affinity, advancing understanding of molecular recognition processes in biological systems.

Peptide synthesis validation: As a model pentapeptide, Leu-Pro-Phe-Phe-Asp is often employed in the optimization and validation of solid-phase peptide synthesis techniques. Its sequence complexity, including both hydrophobic and polar elements, presents a practical challenge for evaluating coupling efficiency, resin compatibility, and deprotection strategies. By synthesizing and analyzing this peptide, laboratories can benchmark their synthetic protocols, assess product integrity using analytical methods such as HPLC or mass spectrometry, and refine methodologies for the preparation of more complex peptide targets.

Enzymatic substrate studies: The pentapeptide's sequence is well-suited for use as a substrate in enzymatic assays, particularly those investigating protease specificity or peptidase activity. By monitoring its cleavage or modification under controlled conditions, researchers can gain insights into enzyme substrate preferences, catalytic mechanisms, or inhibitor screening. Such studies are instrumental in characterizing enzyme kinetics, substrate turnover, and the development of biochemical assays for high-throughput screening or mechanistic enzymology.

Peptide-based material science: Beyond its applications in classical biochemistry, Leu-Pro-Phe-Phe-Asp can be incorporated into studies exploring peptide-based materials or nanostructures. Its sequence, which combines hydrophobic and acidic residues, may influence self-assembly, aggregation, or surface interactions, making it a candidate for the development of biomimetic coatings, hydrogels, or nanomaterials. Investigations in this area contribute to the broader understanding of peptide-driven material properties and the design of functional biomaterials for research and industrial applications.

1. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

2. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

3. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats